- Home
- CROX vs OPCH Comparison
CROX vs OPCH Comparison
Compare CROX & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$75.67
HOLD
Current Price
$28.16
Company Overview
Basic Information| Metric | CROX | OPCH |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.9B |
| IPO Year | 2005 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CROX | OPCH |
|---|---|---|
| Price | $75.67 | $28.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $94.44 | $37.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 1.27 |
| Revenue | $4,040,647,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $1.94 | $7.53 |
| Revenue Next Year | $2.40 | $8.58 |
| P/E Ratio | ★ N/A | $22.94 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $73.21 | $24.24 |
| 52 Week High | $116.11 | $36.80 |
Technical Indicators
Market Signals| Indicator | CROX | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 32.39 | 25.28 |
| Support Level | $74.92 | $27.04 |
| Resistance Level | $88.20 | $28.90 |
| Average True Range (ATR) | 2.87 | 0.99 |
| MACD | -1.08 | -0.12 |
| Stochastic Oscillator | 0.34 | 2.96 |
Price Performance
Historical Comparison CROX
OPCH
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.